James E Flynn Insider Trading for August 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James E Flynn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of James E Flynn for August 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 11 2014 | EHTH | eHealth, Inc. | Flynn James E | 10% Owner | Buy | P | 21.05 | 1,731 | 36,438 | 1,251,903 | 1.3 M to 1.3 M (+0.14 %) |
| Aug 11 2014 | EHTH | eHealth, Inc. | Flynn James E | 10% Owner | Buy | P | 21.05 | 1,400 | 29,470 | 1,012,685 | 1 M to 1 M (+0.14 %) |
| Aug 05 2014 | EHTH | eHealth, Inc. | Flynn James E | 10% Owner | Buy | P | 20.99 | 2,085 | 43,764 | 1,250,172 | 1.2 M to 1.3 M (+0.17 %) |
| Aug 05 2014 | EHTH | eHealth, Inc. | Flynn James E | 10% Owner | Buy | P | 20.99 | 1,685 | 35,368 | 1,011,285 | 1 M to 1 M (+0.17 %) |
| Aug 05 2014 | EHTH | eHealth, Inc. | Flynn James E | 10% Owner | Buy | P | 20.75 | 78,853 | 1,636,200 | 1,248,087 | 1.2 M to 1.2 M (+6.74 %) |
| Aug 05 2014 | EHTH | eHealth, Inc. | Flynn James E | 10% Owner | Buy | P | 20.40 | 7,122 | 145,289 | 1,169,234 | 1.2 M to 1.2 M (+0.61 %) |
| Aug 05 2014 | EHTH | eHealth, Inc. | Flynn James E | 10% Owner | Buy | P | 20.75 | 63,738 | 1,322,564 | 1,009,600 | 945.9 K to 1 M (+6.74 %) |
| Aug 05 2014 | EHTH | eHealth, Inc. | Flynn James E | 10% Owner | Buy | P | 20.40 | 5,757 | 117,443 | 945,862 | 940.1 K to 945.9 K (+0.61 %) |
| Aug 05 2014 | EHTH | eHealth, Inc. | Flynn James E | 10% Owner | Buy | P | 19.40 | 13,272 | 257,477 | 1,162,112 | 1.1 M to 1.2 M (+1.16 %) |
| Aug 05 2014 | EHTH | eHealth, Inc. | Flynn James E | 10% Owner | Buy | P | 19.04 | 80,904 | 1,540,412 | 1,148,840 | 1.1 M to 1.1 M (+7.58 %) |
| Aug 05 2014 | EHTH | eHealth, Inc. | Flynn James E | 10% Owner | Buy | P | 19.40 | 10,728 | 208,123 | 940,105 | 929.4 K to 940.1 K (+1.15 %) |
| Aug 05 2014 | EHTH | eHealth, Inc. | Flynn James E | 10% Owner | Buy | P | 19.04 | 65,396 | 1,245,140 | 929,377 | 864 K to 929.4 K (+7.57 %) |
| Aug 06 2014 | LOXO | Loxo Oncology, Inc ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 222,839 | 0 | 0 | |
| Aug 06 2014 | LOXO | Loxo Oncology, Inc ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 279,051 | 0 | 0 | |
| Aug 06 2014 | LOXO | Loxo Oncology, Inc ... | Flynn James E | 10% Owner | Buy | P | 13.05 | 77,256 | 1,008,191 | 296,125 | 218.9 K to 296.1 K (+35.30 %) |
| Aug 06 2014 | LOXO | Loxo Oncology, Inc ... | Flynn James E | 10% Owner | Buy | P | 13.00 | 218,869 | 2,845,297 | 218,869 | 0 to 218.9 K |
| Aug 06 2014 | LOXO | Loxo Oncology, Inc ... | Flynn James E | 10% Owner | Buy | P | 13.05 | 62,400 | 814,320 | 239,300 | 176.9 K to 239.3 K (+35.27 %) |
| Aug 06 2014 | LOXO | Loxo Oncology, Inc ... | Flynn James E | 10% Owner | Buy | P | 13.00 | 176,900 | 2,299,700 | 176,900 | 0 to 176.9 K |
| Aug 06 2014 | LOXO | Loxo Oncology, Inc ... | Flynn James E | 10% Owner | Buy | P | 13.00 | 246,631 | 3,206,203 | 469,470 | 222.8 K to 469.5 K (+110.68 %) |
| Aug 06 2014 | LOXO | Loxo Oncology, Inc ... | Flynn James E | 10% Owner | Buy | P | 13.00 | 307,600 | 3,998,800 | 586,651 | 279.1 K to 586.7 K (+110.23 %) |
| Aug 06 2014 | LOXO | Loxo Oncology, Inc ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 222,839 | 0 | 222,839 | 0 to 222.8 K |
| Aug 06 2014 | LOXO | Loxo Oncology, Inc ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 279,051 | 0 | 279,051 | 0 to 279.1 K |
| Aug 05 2014 | AAVL | Adverum Biotechnol ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 531,208 | 0 | 0 | |
| Aug 05 2014 | AAVL | Adverum Biotechnol ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 147,410 | 0 | 0 | |
| Aug 05 2014 | AAVL | Adverum Biotechnol ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 184,594 | 0 | 0 | |
| Aug 05 2014 | AAVL | Adverum Biotechnol ... | Flynn James E | 10% Owner | Buy | P | 24.57 | 31,650 | 777,641 | 627,267 | 595.6 K to 627.3 K (+5.31 %) |
| Aug 05 2014 | AAVL | Adverum Biotechnol ... | Flynn James E | 10% Owner | Buy | P | 26.35 | 49,981 | 1,316,999 | 595,617 | 545.6 K to 595.6 K (+9.16 %) |
| Aug 05 2014 | AAVL | Adverum Biotechnol ... | Flynn James E | 10% Owner | Buy | P | 26.14 | 27,600 | 721,464 | 545,636 | 518 K to 545.6 K (+5.33 %) |
| Aug 05 2014 | AAVL | Adverum Biotechnol ... | Flynn James E | 10% Owner | Buy | P | 27.54 | 12,400 | 341,496 | 518,036 | 505.6 K to 518 K (+2.45 %) |
| Aug 05 2014 | AAVL | Adverum Biotechnol ... | Flynn James E | 10% Owner | Buy | P | 26.42 | 219,864 | 5,808,807 | 505,636 | 285.8 K to 505.6 K (+76.94 %) |
| Aug 05 2014 | AAVL | Adverum Biotechnol ... | Flynn James E | 10% Owner | Buy | P | 25.79 | 18,700 | 482,273 | 285,772 | 267.1 K to 285.8 K (+7.00 %) |
| Aug 05 2014 | AAVL | Adverum Biotechnol ... | Flynn James E | 10% Owner | Buy | P | 25.52 | 9,800 | 250,096 | 267,072 | 257.3 K to 267.1 K (+3.81 %) |
| Aug 05 2014 | AAVL | Adverum Biotechnol ... | Flynn James E | 10% Owner | Buy | P | 25.41 | 201,972 | 5,132,109 | 257,272 | 55.3 K to 257.3 K (+365.23 %) |
| Aug 05 2014 | AAVL | Adverum Biotechnol ... | Flynn James E | 10% Owner | Buy | P | 17.00 | 55,300 | 940,100 | 55,300 | 0 to 55.3 K |
| Aug 05 2014 | AAVL | Adverum Biotechnol ... | Flynn James E | 10% Owner | Buy | P | 24.57 | 25,600 | 628,992 | 507,200 | 481.6 K to 507.2 K (+5.32 %) |
| Aug 05 2014 | AAVL | Adverum Biotechnol ... | Flynn James E | 10% Owner | Buy | P | 26.35 | 40,400 | 1,064,540 | 481,600 | 441.2 K to 481.6 K (+9.16 %) |
| Aug 05 2014 | AAVL | Adverum Biotechnol ... | Flynn James E | 10% Owner | Buy | P | 26.14 | 22,400 | 585,536 | 441,200 | 418.8 K to 441.2 K (+5.35 %) |
| Aug 05 2014 | AAVL | Adverum Biotechnol ... | Flynn James E | 10% Owner | Buy | P | 27.54 | 10,100 | 278,154 | 418,800 | 408.7 K to 418.8 K (+2.47 %) |
| Aug 05 2014 | AAVL | Adverum Biotechnol ... | Flynn James E | 10% Owner | Buy | P | 26.42 | 177,700 | 4,694,834 | 408,700 | 231 K to 408.7 K (+76.93 %) |
| Aug 05 2014 | AAVL | Adverum Biotechnol ... | Flynn James E | 10% Owner | Buy | P | 25.79 | 15,100 | 389,429 | 231,000 | 215.9 K to 231 K (+6.99 %) |
| Aug 05 2014 | AAVL | Adverum Biotechnol ... | Flynn James E | 10% Owner | Buy | P | 25.52 | 7,900 | 201,608 | 215,900 | 208 K to 215.9 K (+3.80 %) |
| Aug 05 2014 | AAVL | Adverum Biotechnol ... | Flynn James E | 10% Owner | Buy | P | 25.41 | 163,300 | 4,149,453 | 208,000 | 44.7 K to 208 K (+365.32 %) |
| Aug 05 2014 | AAVL | Adverum Biotechnol ... | Flynn James E | 10% Owner | Buy | P | 17.00 | 44,700 | 759,900 | 44,700 | 0 to 44.7 K |
| Aug 05 2014 | AAVL | Adverum Biotechnol ... | Flynn James E | 10% Owner | Buy | P | 17.00 | 123,077 | 2,092,309 | 654,285 | 531.2 K to 654.3 K (+23.17 %) |
| Aug 05 2014 | AAVL | Adverum Biotechnol ... | Flynn James E | 10% Owner | Buy | P | 17.00 | 34,223 | 581,791 | 181,633 | 147.4 K to 181.6 K (+23.22 %) |
| Aug 05 2014 | AAVL | Adverum Biotechnol ... | Flynn James E | 10% Owner | Buy | P | 17.00 | 42,700 | 725,900 | 227,294 | 184.6 K to 227.3 K (+23.13 %) |
| Aug 05 2014 | AAVL | Adverum Biotechnol ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 531,208 | 0 | 531,208 | 0 to 531.2 K |
| Aug 05 2014 | AAVL | Adverum Biotechnol ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 147,410 | 0 | 147,410 | 0 to 147.4 K |
| Aug 05 2014 | AAVL | Adverum Biotechnol ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 184,594 | 0 | 184,594 | 0 to 184.6 K |